NAD(P)H oxidase isoform Nox2 plays a prosurvival role in human leukaemia cells

Free Radical Research

Volumn 43, Issue 11, 2009, Pages 1111-1121

  Maraldi, Tullia ^a   Prata, Cecilia ^b   Vieceli Dalla Sega, Francesco ^b   Caliceti, Cristiana ^b   Zambonin, Laura ^b   Fiorentini, Diana ^b   Hakim, Gabriele ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apoptosis; Glucose transport; Interleukin 3; Megakaryocytic cells; NAD(P)H oxidase; Reactive oxygen species

Indexed keywords

ANTILEUKEMIC AGENT; APOCYNIN; DIPHENYLIODONIUM SALT; GLUCOSE; GLUCOSE TRANSPORTER 1; INTERLEUKIN 3; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMALL INTERFERING RNA; STEM CELL FACTOR RECEPTOR; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; ACUTE GRANULOCYTIC LEUKEMIA; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; GLUCOSE TRANSPORTER TYPE 1; HUMANS; INTERLEUKIN-3; LEUKEMIA, MYELOID, ACUTE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES;

EID: 70350534699     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760903186132     Document Type: Article

References (49)

1. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002;397:342-344
2. Bokoch GM, Knaus UG. NADPH oxidases: not just for leukocytes anymore! Trends Biochem Sci 2003;28:502-508
3. Brar SS, Corbin Z, Kennedy TP, Hemendinger R, Thornton L, Bommarius B, Arnold RS, Whorton AR, Sturrock AB, Huecksteadt TP, Quinn MT, Krenitsky K, Ardie KG, Lambeth JD, Hoidal JR. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol 2003;285:C353-C369
4. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001;11:173-186
5. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, Symons M, Borrello S, Galeotti T, Ramponi G. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 2003;161:933-944
6. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol 2003;285:R277-R297
7. Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000;5:415-418
8. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 2004;279:34643-34654
9. Wedgwood S, Black SM. Induction of apoptosis in fetal pulmonary arterial smooth muscle cells by a combined superoxide dismutase/catalase mimetic. Am J Physiol Lung Cell Mol Physiol 2003;285:L305-L312 (Pubitemid 36909446)
10. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol 2000;279:L1005-L1028
11. Fiorentini D, Hakim G, Bonsi L, Bagnara GP, Maraldi T, Landi L. Acute regulation of glucose transport in a human megakaryocytic cell line: differences between growth factors and H2O2. Free Radic Biol Med 2001;31:923-931
12. Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2005;202:654-662
13. Clement MV, Stamenkovic I. Superoxide anion is a natural inhibitor of FAS-mediated cell death. EMBO J 1996;15: 216-225
14. Lin KI, Pasinelli P, Brown RH, Hardwick JM, Ratan RR. Decreased intracellular superoxide levels activate Sindbis virus-induced apoptosis. J Biol Chem 1999;274:13650-13655
15. Maraldi T, Prata C, Fiorentini D, Zambonin L, Landi L, Hakim G. Induction of apoptosis in a human leukemic cell line via reactive oxygen species modulation by antioxidants. Free Radic Biol Med 2009;46:244-252
16. Advani AS. FLT3 and acute myelogenous leukemia: biology, clinical significance and therapeutic applications. Curr Pharm Des 2005;11:3449-3457
17. Fiorentini D, Prata C, Maraldi T, Zambonin L, Hakim G, Landi L. ROS contribution to the regulation of GLUT1 in two hemopoietic cell lines differing in cytokine sensitivity. Free Radic Biol Med 2004;37:1402-1411
18. Prata C, Maraldi T, Fiorentini D, Zambonin L, Hakim G, Landi L. Nox-generated ROS modulate glucose uptake in a leukaemic cell line. Free Radic Res 2008;42:405-414
19. Maraldi T, Rugolo M, Fiorentini D, Landi L, Hakim G. Glucose transport activation in human hematopoietic cells M07e is modulated by cytosolic calcium and calmodulin. Cell Calcium 2006;4:373-381
20. Piccoli C, D'Aprile A, Ripoli M, Scrima R, Lecce L, Boffoli D, Tabilio A, Capitanio N. Bone-marrow derived hematopoietic stem/progenitor cells express multiple isoforms of NADPH oxidase and produce constitutively reactive oxygen species. Biochem Biophys Res Commun 2007;353:965-972
21. Prata C, Maraldi T, Zambonin L, Fiorentini D, Hakim G, Landi L. ROS production and Glut1 activity in two human megakaryiocytic cell lines. Biofactors 2004;20:223-233
22. Miller AA, Drummond GR, Sobey CG. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol Ther 2006;111:928-948
23. Schmidt-Arras D, Schwable J, Bohmer FD, Serve H. Flt3 receptor tyrosine kinase as a drug target in leukemia. Curr Pharm Des 2004;10:1867-1883
24. Spiekermann K, Faber F, Voswinckel R, Hiddemann W. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells. Exp Hematol 2002;30:767-773
25. Luskova P, Draber P. Modulation of the Fcepsilon receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases. Curr Pharm Des 2004;10:1727-1737
26. Berton G, Mocsai A, Lowell C. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol 2005;26:208-214
27. Bentley J, Itchayanan D, Barnes K, McIntosh E, Tang X, Downes CP, Holman GD, Whetton AD, Owen-Lynch PJ, Baldwin SA. Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface. J Biol Chem 2003;278:39337-39348
28. Kawanabe Y, Hashimoto N, Masaki T Role of phosphoinosi-tide 3-kinase in the nonselective cation channel activation by endothelin-1/endothelin B receptor. Am J Physiol Cell Physiol 2003;284:C506-C510
29. Hajduch E, Alessi DR, Hemmings BA, Hundal HS. Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 1998;47:1006-1013
30. Wang Y, Wu J, Wang Z. Akt binds to and phosphorylates phospholipase C-gamma1 in response to epidermal growth factor. Mol Biol Cell 2006;17:2267-2277
31. Maraldi T, Fiorentini D, Prata C, Landi L, Hakim G. Stem cell factor and H2O2 induce GLUT1 translocation in M07e cells. Biofactors 2004;20:97-108
32. Agnetti G, Maraldi T, Fiorentini D, Giordano E, Prata C, Hakim G, Muscari C, Guarnieri C, Caldarera CM. Activation of glucose transport during simulated ischemia in H9c2 cardiac myoblasts is mediated by protein kinase C isoforms. Life Sci 2005;78:264-270
33. Katsanakis KD, Owen C, Zoumpourlis V. JNK and ERK signaling pathways in multistage mouse carcinogenesis: studies in the inhibition of signaling cascades as a means to understand their in vivo biological role. Anticancer Res 2002;22:755-759
34. Bruton JD, Katz A, Westerblad H. The role of Ca + and calmodulin in insulin signalling in mammalian skeletal muscle. Acta Physiol Scand 2001;171:259-265
35. Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K. 2APB, 2-aminoethoxy-diphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3 induced calcium release. J Biochem 1997;122:498-505
36. Linnekin D. Early signaling pathways activated by c-kit in hematopoietic cells. Int J Biochem Cell Biol 1999;31: 1053-1074
37. Maraldi T, Fiorentini D, Prata C, Landi L, Hakim G. Glucose-transport regulation in leukemic cells: how can H2O2 mimic stem cell factor effects? Antioxid Redox Signal 2007;9:271-279
38. Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 2008;266:37-52
39. Dong JM, Zhao SG, Huang GY, Liu Q. NADPH oxidase-mediated generation of reactive oxygen species is critically required for survival of undifferentiated human promyelocytic leukemia cell line HL-60. Free Radic Res 2004;38:629-637
40. Ushio-Fukai M. Compartmentalization of Redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 2009;11:1289-1299
41. Li Q, Spencer NY, Oakley FD, Buettner GR, Engelhardt J. Endosomal Nox2 facilitates Redox-dependent induction of NFK-B by TNFalpha. Antioxid Redox Signal 2009;11: 1249-1263
42. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313
43. Arai A, Kanda E, Miura O. Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway. Oncogene 2002;21:2641-2651
44. Finkel T Intracellular redox regulation by the family of small GTPases. Antioxid Redox Signal 2006;8:1857-1863
45. Pelletier S, Duhamel F, Coulombe P, Popoff MR, Meloche S. Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol Cell Biol 2003;23:1316-1333
46. Mehdi MZ, Pandey NR, Pandey SK, Srivastava AK. H2O2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid Redox Signal 2005;7:1014-1020
47. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 2001;21:5899-5912
48. Smolich BD, Yuen HA, West KA, Giles FJ, Albitar M, Cherrington JM. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. Blood 2001;97:1413-1421
49. Scott CL, Robb L, Papaevangeliou B, Mansfield R, Nicola NA, Begley CG. Reassessment of interactions between hematopoietic receptors using common beta-chain and inter-leukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony-stimulating factor, or stem cell factor. Blood 2000;96:1588-1590.